Reports From the Field

A Service Evaluation of Acute Neurological Patients Managed on Clinically Inappropriate Wards


 

References

The average length of stay was 25.9 days (range, 2-78 days). This was more than double the average length of stay on the stroke ward (11.4 days) (Table 1) and the national average for patients with neurological conditions (9.78 days).10 During their stay, 33% had 2 or more ward moves, with 1 patient moving wards a total of 6 times. Just over half (52.4%) of the patients returned to their usual residence on discharge. The remainder were discharged to rehabilitation units (15.9%), nursing homes (14.3%), residential homes (6.3%), tertiary centers (4.8%), and hospice (1.6%). Unfortunately, 3 patients (4.8%) passed away. Of those still alive (n = 60), 16.7% were readmitted to the hospital within 30 days, compared to a readmission rate of 11% on the stroke ward. None of the patients who were readmitted were seen by a neurologist during their initial admission.

The frequency of secondary complications was reviewed as a measure of the multidisciplinary management of this patient group. It was noted that 11.1% had a fall on the ward, which was similar to a rate of 10.7% on the stroke ward. More striking was the fact that 14.3% of patients developed a pressure ulcer and 33.3% developed an HAI during their admission, compared with rates of 1.3% and 10.7%, respectively, on the stroke ward (Table 1).

There were no significant differences found in length of stay between those who were and were not reviewed by a neurologist (P = .73). This was also true for categorical data, whereby readmission rate (P = .13), frequency of falls (P = .22), frequency of pressure ulcers (P = .67), and HAIs (P = .81) all failed to show a significant difference between groups.

Discussion

The findings of this service evaluation show markedly poorer outcomes for neurological patients compared to stroke patients managed on a specialist stroke ward. It is suggested that these results are in part due to the lack of specialist input from a neurologist in the majority of cases and the fact that all were managed on clinically inappropriate wards. Only 15.9% of neurological patients were seen by a neurologist. This is a slight improvement compared to previous studies in DGHs that showed rates of 10%1 and 11%,11 but it is still a far cry from the goal of 100% set out in recommendations.2 In addition, the increased readmission rate may be suggestive of suboptimal management, especially given that none of those readmitted had been reviewed by a neurologist. There are undoubtedly other factors that may influence readmissions, such as comorbidities, the severity/complexity of the condition, and the strength of community services. However, the impact of a lack of input from a specialist should not be underestimated, and further evaluation of this factor (with confounding factors controlled) would be beneficial.

The result of an extended length of stay was also a predictable outcome based on previous evidence.4,5 With the potential for suboptimal management plans and inaccurate diagnoses, it is inevitable that the patient’s movement through the hospital system will be impeded. In our example, it is possible that the extended length of stay was influenced by the fact that patients included in the evaluation were managed on nonspecialist wards and a large proportion had multiple ward changes.

Pages

Recommended Reading

Watch for abnormal movements in hospitalized COVID-19 patients
Journal of Clinical Outcomes Management
Stroke is ‘not a common complication’ in COVID-19
Journal of Clinical Outcomes Management
Infective endocarditis from IV drug use tied to hemorrhagic stroke
Journal of Clinical Outcomes Management
Some MS treatments may heighten COVID risk
Journal of Clinical Outcomes Management
Insomnia? Referral, drugs not usually needed
Journal of Clinical Outcomes Management
High teen BMI linked to stroke risk in young adulthood
Journal of Clinical Outcomes Management
Race, ethnicity, and socioeconomics are often barriers to migraine care
Journal of Clinical Outcomes Management
Healthy lifestyle can reduce dementia risk despite family history
Journal of Clinical Outcomes Management
Large vessel stroke linked to AstraZeneca COVID vaccine
Journal of Clinical Outcomes Management
New AHA/ASA guideline on secondary stroke prevention
Journal of Clinical Outcomes Management